ArticleJournal of enzyme inhibition and medicinal chemistry2024

Design, synthesis, and evaluation of novel stilbene derivatives that degrade acidic nucleoplasmic DNA-binding protein 1 (And1) and synergize with PARP1 inhibitor in NSCLC cells.

Leyuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.